How Can Digital Health Tools Address Health Equity and Access in Underserved Populations?

I. Introduction Health equity refers to the attainment of the highest level of health for all people, ensuring that no one is disadvantaged from achieving this potential because of social, economic...

How do we ensure interoperability between Electronic Health Records (EHRs) across platforms and borders?

1. Introduction to EHR Interoperability Definition and Core ConceptElectronic Health Record (EHR) interoperability refers to the capability of different healthcare information systems, devices, and...

How Can AI and Machine Learning Be Safely and Effectively Integrated into Clinical Decision-Making?

1. Introduction The Emergence of AI and ML in Healthcare Artificial Intelligence (AI) and Machine Learning (ML) have emerged as transformative forces in the healthcare industry. Their capacity to...

How can manufacturers ensure Clinical Evaluation Reports (CERs) meet the expectations of Notified Bodies (NBs) under EU MDR?

Understanding Clinical Evaluation Reports (CERs) in EU MDR Definition and Purpose of Clinical Evaluation Reports (CERs) A Clinical Evaluation Report (CER) is a critical technical document required...

What Are the Real Consequences of EU MDR on Legacy Devices and Patient Care Access?

1. Understanding the Term “Legacy Devices” Under EU MDR Definition of Legacy Devices under EU MDR Under the European Union Medical Device Regulation (EU MDR 2017/745), “legacy devices” refer to...

How Are Custom-Made Devices and Niche Markets Being Affected by EU MDR?

1. Definition & Regulatory Context Definition of Custom-Made Devices (CMDs) Under Article 2(3) of the EU MDR, a custom-made device is defined as any medical device specifically made in accordance...

What Are the Implications of MDR for Software as a Medical Device (SaMD)?

1. Introduction: What is SaMD? Definition of SaMD Software as a Medical Device (SaMD) refers to software that is intended to perform medical functions without being part of a hardware medical device...

How Should Manufacturers Handle Post-Market Surveillance (PMS) and Post-Market Clinical Follow-up (PMCF) Obligations Effectively Under EU MDR?

Background: Why PMS & PMCF are Game-Changers under EU MDR Regulatory Evolution: From MDD to MDR Under the previous Medical Device Directive (MDD 93/42/EEC), Post-Market Surveillance (PMS) and...

How Can Small and Medium Enterprises (SMEs) Survive Under MDR’s Regulatory Burden?

Background Context The EU Medical Device Regulation (MDR 2017/745) came into force in May 2021 (with transition timelines extended to 2028/2029 in some cases via Regulation (EU) 2023/607). It...
error: Content is protected !!